ST 2825 - CAS# 894787-30-5 Size:Solid 10 mg 43 μM) and causes altered

43 μM) and causes altered cell cycle progression most clearly revealed under conditions of recovery from serum starvation

Molecular Weight: 158

PubMed PMID: 30937854

Formulations containing lodoxamide have been used in the treatment of vernal conjunctivitis and keratitis

BCX-4430 freebase

ST 2825 - CAS# 894787-30-5 Size:Solid 10 mg 43 μM) and causes alteredST 2825 is MyD88 inhibitor. ST2825 provides neuroprotection after experimental traumatic brain injury in mice. ST2825 significantly inhibited the proliferation of and promoted the apoptosis of HCC cells. Moreover, ST2825 significantly decreased bcl 2 expression, increased cleaved caspase 3 expression (P < 0. 05), and reduced p65 nuclear expression (P < 0. 05) in a dose dependent manner. ST2825 inhibits the proliferation of and promotes the apoptosis